KC
MRK icon

Kinloch Capital’s Merck MRK Stock Holding History

Kinloch Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Sell
4,363
-49
-1% -$5.66K 0.21% 58
2025
Q4 		$464K Buy
4,412
+48
+1% +$4.51K 0.2% 55
2025
Q3 		$366K Buy
4,364
+23
+0.5% +$1.89K 0.16% 60
2025
Q2 		$344K Sell
4,341
-67
-2% -$5.33K 0.16% 61
2025
Q1 		$396K Buy
4,408
+50
+1% +$4.67K 0.19% 61
2024
Q4 		$434K Buy
4,358
+16
+0.4% +$1.65K 0.22% 59
2024
Q3 		$493K Sell
4,342
-1
-0% -$119 0.24% 59
2024
Q2 		$538K Buy
4,343
+264
+6% +$34K 0.28% 55
2024
Q1 		$538K Buy
4,079
+1,846
+83% +$228K 0.28% 53
2023
Q4 		$243K Sell
2,233
-1,959
-47% -$203K 0.15% 65
2023
Q3 		$432K Buy
4,192
+2,218
+112% +$239K 0.27% 52
2023
Q2 		$228K Sell
1,974
-2,189
-53% -$249K 0.14% 63
2023
Q1 		$443K Buy
4,163
+14
+0.3% +$1.51K 0.26% 48
2022
Q4 		$460K Buy
4,149
+17
+0.4% +$1.74K 0.27% 46
2022
Q3 		$356K Buy
4,132
+15
+0.4% +$1.34K 0.23% 52
2022
Q2 		$375K Buy
4,117
+219
+6% +$19.4K 0.24% 52
2022
Q1 		$320K Buy
3,898
+440
+13% +$34.7K 0.19% 58
2021
Q4 		$265K Buy
3,458
+17
+0.5% +$1.35K 0.16% 57
2021
Q3 		$258K Hold
3,441
– – 0.18% 57
2021
Q2 		$268K Sell
3,441
-165
-5% -$12.3K 0.19% 59
2021
Q1 		$265K Hold
3,606
– – 0.2% 56
2020
Q4 		$281K Buy
+3,606
New +$276K 0.24% 56

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kinloch Capital's MRK Position: Q1 2026 in Review

Kinloch Capital reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $5.66K and leaving 4,363 shares worth $525K. The position accounts for 0.21% of the portfolio, ranked #58.

Kinloch Capital first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $538K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kinloch Capital held 4,363 shares of Merck worth $525K as of Q1 2026.
  • Kinloch Capital sold 49 Merck shares in Q1 2026, an estimated $5.66K.
  • Merck made up 0.21% of Kinloch Capital's portfolio in Q1 2026, its #58 holding.
  • Kinloch Capital first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Kinloch Capital's Merck position peaked at $538K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kinloch Capital's 13F filing for Q1 2026, filed 15 May 2026.